Rocket Pharmaceuticals, Inc.
About
3.07USD+0.05 +1.66%
Closed • Updated at 01:48 GMT+00:00Market Cap$335.22M
Volume2.26M
Beta0.94
RSI39.37
Rocket Pharmaceuticals, Inc. — investor relations, events, news, and company updates on 6ix.
Latest News
May 7 2026
Rocket Pharmaceuticals Reports First Quarter 2026 Financial Results and Highlights Recent Progress
Apr 28 2026
Rocket Pharmaceuticals Announces $180 Million Sale of Priority Review Voucher
Mar 27 2026
Rocket Pharmaceuticals Announces FDA Approval of KRESLADI™ for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I)
Feb 26 2026
Rocket Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Highlights Recent Progress
Jan 5 2026
Rocket Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare Conference
Recent Videos
BAG3 DCM Gene Therapy Clinical Trial Studies Webinar Recording 4 15 26
Apr 16, 2026
RCKT Stock Analysis | Rocket Pharmaceuticals, Inc. | April 13, 2026
Apr 11, 2026
RCKT Stock Analysis | Rocket Pharmaceuticals, Inc. | April 10, 2026
Apr 10, 2026
RCKT Stock Analysis | Rocket Pharmaceuticals, Inc. | April 8, 2026
Apr 08, 2026
Community Chat
Ask AI
Try asking